# Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/icotinib-versus-gefitinib-in-previously-treated-advanced-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuankai Shi,Li Zhang,Xiaoqing Liu,Caicun Zhou,Li Zhang,Shucai Zhang,Dong Wang,Qiang Li,Shukui Qin,Chunhong Hu,Yiping Zhang,Jianhua Chen,Ying Cheng,Jifeng Feng,Helong Zhang,Yong Song,Yi‐Long Wu,Nong Xu,Jianying Zhou,Rongcheng Luo,Chunxue Bai,Jin Ye-ning,Wenchao Liu,Zhaohui Wei,Fenlai Tan,Yinxiang Wang,Lieming Ding,Hong Dai,Shunchang Jiao,Jie Wang,Li Liang,Weimin Zhang,Yan Sun |
| Citations | 424 |
| DOI | 10.1016/s1470-2045(13)70355-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2099180737 |
| PMID | 23948351 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Dong Wang](https://scholariq.org/researchers/dong-wang/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.